Definitions

from Wiktionary, Creative Commons Attribution/Share-Alike License

  • n. An antiparkinsonian drug.

Etymologies

Sorry, no etymologies found.

Examples

  • Chelsea recently completed enrollment of 120 patients in its Phase II trial of droxidopa for the treatment of fibromyalgia.

  • The claims of the patent are related to methods of reducing pain associated with fibromyalgia by administering droxidopa alone, or in combination with other specified medications, to patients diagnosed with fibromyalgia.

  • CHTP - News has successfully reached its target enrollment of 120 patients in its Phase II trial of droxidopa for the treatment of fibromyalgia.

  • These risks and uncertainties include risks and costs of drug development, risk of regulatory approvals, our reliance on our lead drug candidates droxidopa and CH-4051, reliance on collaborations and licenses, intellectual property risks, our need to raise additional operating capital in the future, our history of losses, competition, market acceptance for our products if any are approved for marketing, and reliance on key personnel including specifically Dr. Pedder.

  • While NE, as a catecholamine does not penetrate the blood-brain barrier, droxidopa, as a neutral amino acid, is able to do so thus providing both a peripheral and central affect on circulating NE levels.

  • FMS201 is a multicenter, randomized, double-blind, placebo-controlled Phase II trial designed to investigate several dosing options for droxidopa, both alone an in combination with carbidopa.

  • Chelsea's most advanced drug candidate, NORTHERA(TM) (droxidopa), is an orally active synthetic precursor of norepinephrine initially being developed for the treatment of neurogenic orthostatic hypotension.

  • "As we continue to work towards an approval for droxidopa for the treatment of neurogenic orthostatic hypotension, we are eager to expand the body of clinical research supporting potential indications that could be effectively treated with norepinephrine replacement therapy," said Dr. Simon Pedder, president and CEO of Chelsea.

    News

  • Chelsea's most advanced drug candidate, Northera ™ (droxidopa), is an orally active synthetic precursor of norepinephrine initially being developed for the treatment of neurogenic orthostatic hypotension.

    News

  • The trial will evaluate up to 600 mg TID of droxidopa and assess the clinical efficacy using changes in

    News

Comments

Log in or sign up to get involved in the conversation. It's quick and easy.